Wave of illness subsides on Caribbean cruise

January 2, 2013

The cruise line that operates the Queen Mary 2 says an apparent outbreak of gastrointestinal illness has subsided as the ship heads back to port.

Cunard Line spokeswoman Jackie Chase says just two passengers had suspected cases of norovirus on Tuesday. That's down from 201 cases reported by the U.S. Centers for Disease Control as the ship made its way through the Caribbean on a 12-night voyage with more than 2,600 passengers.

Norovirus is easily transmittable and typically results in vomiting and diarrhea. The CDC and Cunard say the crew of the Queen Mary 2 took steps to halt the spread of the virus such as deploying teams to do additional cleaning of public areas with disinfectant.

The ship returns to New York on Wednesday.

Explore further: 19 ill in suspected norovirus outbreak on liner

shares

Related Stories

19 ill in suspected norovirus outbreak on liner

December 28, 2012

Nineteen people aboard the cruise ship Queen Mary 2 have been diagnosed with a gastrointestinal illness as the liner docked Friday in the Caribbean island of St. Lucia.

Vomiting bug-hit cruise ship back in Britain

December 14, 2012

A liner hit by the winter vomiting bug during a pre-Christmas cruise arrived back in port in England on Friday after one passenger dubbed it a "plague ship".

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.